Remote patient monitoring will enhance the care of CHF and GLP-1 patients in 2025
The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for everyday health, chronic condition management, and promoting health equity.
Oren Nissim is CEO and co-founder of Brook Health, a care management company that uses telehealth and AI for home care. He sees big things for RPM in 2025, helping in a variety of areas important to the patients who live there. We spoke to him about the trends he sees shaping up for next year.
Question: You’re predicting big things for congestive heart failure and remote patient monitoring this year. What do you see happening?
A. The year 2025 will transform the management of congestive heart failure as healthcare organizations realize that traditional episodic care models cannot effectively manage the growing number of congestive heart failure patients. Remote patient monitoring will mature beyond simple vital signs tracking to become an intelligent early warning system that combines real-time physiological data with AI-based pattern recognition to detect subtle signs of deterioration days before serious symptoms appear.
The integration of AI-powered monitoring with human care teams will enable a new standard for proactive management of chronic heart failure. Healthcare organizations will implement sophisticated triage protocols that automatically escalate concerning patterns to clinical teams, providing patients with personalized guidance for daily self-management.
This combination will significantly reduce the burden on emergency departments while improving patient outcomes.
The most significant impact will come from being able to deliver specialized CHF expertise into each patient’s home. Remote patient monitoring platforms will enable cardiologists to expand their reach beyond geographic boundaries, provide expert guidance to local care teams and ensure every patient with congestive heart failure receives expert-level care regardless of location.
Question: Another area of RPM that you say will see a lot of activity is working with GLP-1 drugs, which are medications prescribed for diabetes control and weight loss. How will these two aspects of care be combined?
A. The year 2025 will mark a critical intersection between the GLP-1 revolution and remote patient monitoring as healthcare organizations seek to support unprecedented numbers of patients on these transformative medicines.
Combining the powerful effects of GLP-1s on many chronic conditions with continuous remote monitoring will create opportunities for more precise drug management and early intervention when problems arise.
Healthcare organizations will develop advanced remote patient monitoring protocols specifically designed for patients using GLP-1, tracking not only weight and vital signs, but also medication adherence, side effects and effects on multiple conditions including diabetes, heart failure and obesity.
This comprehensive monitoring will enable care teams to optimize dosing, manage side effects and ensure patients get the most out of these expensive medications.
Integrating remote patient monitoring with GLP-1 therapy will generate unprecedented insights into the real-world effects of these drugs on the development of chronic diseases. These data will enable healthcare organizations to identify patients most likely to benefit from GLP-1s, predict potential complications and develop more effective protocols for managing multiple chronic conditions simultaneously.
Q: Health equity is a big, big topic in health care today. Where do you see progress this year?
A. The year 2025 will reveal the greatest potential of telecare to address long-standing health care inequalities by providing high-quality chronic disease management in underserved communities. Healthcare organizations will develop culturally competent telehealth programs that combine RPM technology with human support to overcome language, health literacy, and trust barriers that have historically limited telehealth adoption in vulnerable populations.
The most successful programs will extend beyond traditional clinical monitoring to address social determinants of health, integrating community health workers into remote care teams, and linking patients to local resources for nutrition, transportation, and social support.
This comprehensive approach will demonstrate that technology, when properly combined with the human touch, can bridge historical gaps in access to and quality of care.
The impact on health equity will be particularly evident in underserved rural and urban areas, where telecare will enable local primary care providers to manage complex chronic conditions with specialist-level support. By providing expert guidance and ongoing monitoring to communities that have historically lacked access to specialized care, these programs will begin to close long-standing disparities in chronic disease outcomes.
Follow Bill’s HIT coverage on LinkedIn: Bill Siwicki
Email him: bsiwicki@himss.org
Healthcare IT News is a HIMSS media publication